ADVERTISEMENT
Sponsored
Videos
Tara Graff, DO, Talks About Acalabrutinib and How the CLL Treatment Landscape has Evolved
01/01/2021
In this video, Dr Graff, Mission Cancer and Blood, Des Moines, Iowa, talks about how the treatment landscape for chronic lymphocytic leukemia (CLL) has evolved in recent years, especially with the introduction of acalabrutinib (Calquence; AstraZeneca).
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement